June 2022: Burstein: CRISPR in space
An experiment conducted in space, initiated by Dr. David Burstein, Edmond J. Safra member, proved that the CRISPR-Cas can be used for accurate and sensitive genetic diagnostics in space.
An experiment conducted in space, initiated by Dr. David Burstein, Edmond J. Safra member (Life Sciences) and colleagues, proved that the CRISPR-Cas can be used for accurate and sensitive genetic diagnostics in space.
The experiment was performed recently on the International Space Station by Israeli Astronaut Eytan Stibbe as part of the “Rakia” mission, launched to space in April. It demonstrated that the approach could lead to the rapid detection of diseases and pathogens in microgravity environments.
The researchers said that the CRISPR-Cas detection system could be used to monitor the health of personnel and in the future even crops grown in space, as part of long space missions at the International Space Station, as well as to future missions to the Moon and Mars.
The experiment and results were featured in YNET, I24NEWS, Algemeiner and USSANEWS.
Related Articles
